Português•English•Medical education with global reach

Evidence-based medicine

What we know, what remains uncertain, and what has not been proven.

A critical review in U.S. English, with transparent evidence ratings, practical limits, and links to sources readers can verify.

How we rate evidence

Four levels for communicating science honestly.

This is an educational editorial synthesis—not a formal GRADE assessment of one narrowly framed clinical question. Ratings consider study quality, consistency, applicability, and agreement with recognized guidelines.

Strong Convergent guidelines and robust studies.Moderate A probable benefit or association, with relevant limitations.Weak Small, indirect, observational, or inconsistent studies.Insufficient No reliable clinical support for routine use or the promoted claim.

Cognition

Memory concerns and possible early signs of Alzheimer’s disease

Occasional lapses are common. Progressive change is more concerning—especially when it affects independence, finances, navigation, work, communication, or safety.

Strong evidence

Persistent or progressive symptoms deserve a structured evaluation

Evaluation combines the history, input from a trusted person when appropriate, medication review, sleep and mood assessment, a neurologic examination, cognitive testing, and selected laboratory or imaging studies. No single test establishes the diagnosis.

Moderate evidence

Clinicians should look for contributing and potentially treatable factors

Depression, sleep apnea, sedating or anticholinergic drugs, thyroid disease, vitamin B12 deficiency, hearing loss, alcohol use, and vascular disease can contribute. Treating a contributor is appropriate but may not reverse a coexisting neurodegenerative disorder.

Weak evidence

Omega-3 or vitamins as general memory enhancers

Trials do not show consistent cognitive benefit from routine supplementation in adults without a documented deficiency. Vitamin B12 is appropriate when a deficiency or another clinical indication is present.

Insufficient clinical evidence

Online protocols or methylene blue as a routine diagnosis or treatment

No reliable clinical evidence or guideline supports these approaches for routine treatment of memory loss or Alzheimer’s disease. Online quizzes are not diagnostic tests.

Key references

Read the full memory article

Metabolism and weight

Tirzepatide: benefits, risks, and limits

In the United States, Mounjaro and Zepbound contain the same active ingredient but have different FDA-approved indications. Tirzepatide is prescription medication and requires individual screening and follow-up.

Strong evidence

Lower A1C and body weight in the populations studied

Randomized trials show clinically meaningful reductions in A1C and body weight in selected adults with type 2 diabetes and/or obesity. Gastrointestinal adverse effects are common, especially during dose escalation.

Moderate evidence

Benefits beyond the scale depend on the population

Trials support benefits in selected obesity-related conditions, including obstructive sleep apnea. Results from one population should not be assumed for every person seeking weight loss.

Weak evidence

Short-term cosmetic use outside trial populations

Major trials do not establish safety or benefit for normal-weight adults, improvised dosing, a few weeks of use, or unstudied drug combinations.

Insufficient clinical evidence

Guaranteed weight loss or risk-free self-medication

No response is guaranteed. Unapproved, counterfeit, or improperly compounded products may have incorrect ingredients, concentration, sterility, storage, or labeling.

Key references

Read the full tirzepatide article

Nutrition and glucose

Diabetes and breakfast

There is no universal diabetes breakfast. The effect of a meal depends on carbohydrate amount and quality, fiber, protein, fat, medications, activity, and individual glucose response.

Strong evidence

The overall eating pattern matters more than one food

Guidelines support individualized plans emphasizing vegetables, legumes, whole fruit, whole grains, and appropriate protein sources while limiting sugar-sweetened beverages and highly refined foods.

Moderate evidence

Protein and fiber may reduce the meal’s glucose rise

Small trials suggest that replacing a refined-carbohydrate breakfast with a meal containing more protein and/or fiber can reduce the post-meal glucose rise in some settings. The effect varies.

Weak evidence

One required meal time or composition for everyone

Meal timing may influence glucose, but studies are heterogeneous. Routine, hunger, medications, hypoglycemia risk, culture, and preferences matter.

Insufficient clinical evidence

A single food causes, cures, or reverses type 2 diabetes

No isolated food does so. One continuous glucose monitor reading also cannot diagnose diabetes or prove that a food must be banned for everyone.

Key references

Read the full breakfast article

Food choices

Bread, “high-protein” products, fiber, and carbohydrates

“Flourless,” “keto,” and “high protein” are product descriptions—not automatic seals of health. Compare the serving size, total carbohydrate, fiber, protein, sodium, saturated fat, ingredients, and the whole meal.

Strong evidence

Fiber-rich foods and whole grains support metabolic health

Eating patterns rich in fiber, especially from minimally processed foods, are associated with better metabolic outcomes. Replacing some refined grains with whole grains and legumes is consistent with major guidelines.

Moderate evidence

Pairing carbohydrate with protein and fiber may blunt a glucose spike

A mixed meal may slow absorption and improve satiety, but the effect depends on the recipe and portion. A “high-protein” item can still be high in calories, sodium, or saturated fat.

Weak evidence

Glycemic index alone determines whether bread is healthy

Glycemic index can be informative, but preparation, processing, other foods, and the person all modify the response. Glycemic load and nutrient density matter too.

Insufficient clinical evidence

Flourless bread causes weight loss or controls diabetes by itself

Removing flour does not guarantee fewer carbohydrates, fewer calories, or a better glucose response. No bread substitutes for an overall treatment and nutrition plan.

Key references

Women’s health

Hormone testing after age 35

There is no single hormone panel every woman needs at 35. Symptoms, menstrual pattern, age, medications, reproductive goals, and personal history guide evaluation.

Strong evidence

Typical menopause is usually a clinical diagnosis

For otherwise healthy people with compatible symptoms and menstrual changes, routine hormone testing is generally not needed to confirm typical menopause. Menopausal hormone therapy can be effective for appropriate symptoms after individualized risk assessment.

Moderate evidence

Testing is useful in selected situations

FSH and other tests may help with suspected primary ovarian insufficiency, unexplained amenorrhea, atypical timing, or genuine diagnostic uncertainty.

Weak evidence

Broad repeated panels in people without symptoms

Testing many hormones without a clinical question increases incidental findings and may lead to unnecessary labels or treatment. Salivary hormone testing is not validated for routine dose adjustment.

Insufficient clinical evidence

Universal anti-aging replacement or “safer” compounded hormones

Hormone therapy should not be sold as a universal strategy for rejuvenation, weight loss, or prevention of dementia or heart disease. Compounded products are not proven safer or more effective than FDA-approved therapies.

Key references

Thyroid health

Hypothyroidism: diagnosis and treatment

Fatigue, weight change, constipation, dry skin, and mood symptoms are nonspecific. Diagnosis requires symptoms, history, examination, and appropriate testing—not an online symptom list.

Strong evidence

TSH and free T4 are the foundation of primary hypothyroidism evaluation

TSH is commonly the initial test, and free T4 helps classify the abnormality. Levothyroxine is the standard treatment for overt primary hypothyroidism, with individualized dosing and monitoring.

Moderate evidence

Subclinical hypothyroidism requires context

When TSH is elevated and free T4 is normal, the TSH value and persistence, age, symptoms, antibodies, pregnancy status, and cardiovascular risk affect decisions.

Weak evidence

T4/T3 combination or desiccated thyroid for every persistent symptom

Studies have not shown consistent superiority over levothyroxine. Selected cases require careful evaluation and review of other causes; switching is not automatic.

Insufficient clinical evidence

Routine reverse T3, thyroid detoxes, or iodine without deficiency

Reverse T3 is not recommended for routine thyroid assessment. Supplements and excess iodine may cause or worsen thyroid dysfunction.

Key references

Neurologic emergency

Stroke and transient ischemic attack (TIA) warning signs

Stroke can cause sudden trouble with balance, vision, facial droop, arm or leg weakness, speech, or understanding. Time-sensitive treatment can reduce disability.

Strong evidence

Sudden neurologic symptoms require emergency care

Use BE FAST: Balance, Eyes, Face, Arm, Speech, Time. Note the last time the person was known to be well and call emergency services immediately.

Moderate evidence

BE FAST is a screening aid, not a rule-out test

Some strokes cause severe dizziness, poor coordination, double vision, confusion, or other sudden deficits. Missing one classic sign does not exclude stroke.

Weak evidence

Vague symptoms days earlier reliably predict a future stroke

Isolated fatigue, headache, or tingling has many causes. A TIA is different: a sudden focal neurologic deficit that improves still requires emergency evaluation.

Insufficient clinical evidence

Waiting, puncturing fingertips, or giving medicine at home

These actions do not treat stroke and may delay time-sensitive care. Symptoms that resolve still require urgent evaluation.

Key references

Professional responsibility

Health education without remote diagnosis, prescribing, or promises.

This material is general education. Dr. Elias is registered in Brazil, not the United States; this website does not provide U.S. medical services. Professional communication follows Brazilian CFM Resolution No. 2,336/2023.

View the Brazilian CFM rule

Editorial review completed August 29, 2026. Medical evidence changes; pages are reviewed after major guidelines, safety alerts, or new evidence that may change a conclusion.

View editorial policy